Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
National Health Research Institutes, Taiwan
With
National Taiwan University Hospital
Chang Gung Memorial Hospital
Taipei Veterans General Hospital, Taiwan
Mackay Memorial Hospital
Taichung Veterans General Hospital
National Cheng-Kung University Hospital
Kaohsiung Veterans General Hospital.
Kaohsiung Medical University
We expect to collect tissue samples from 270 pancreatic cancer patients of any stages. Since the enrollment criteria are not limited to new patients, we expect to enroll 67 patients a year. The patient enrollment will be completed in 4 years. Clinical follow-up will be completed in another one year. Data analysis and correlation study may be finished in the end of 5th year of this study.
Age
20–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. Patients enrolled to TCOG 3207 study: A Randomized Phase III Study of Adjuvant Gemcitabine versus Gemcitabine Plus Concurrent Chemoradiation in Pancreatic Cancer Underwent Curative Intent (R0 / R1) Resection.
You may not be if
3. Patients have to sign informed consent for tissue specimen collection, according to the regulation of DOH.
Clareo Health | Biomarkers Study in Pancreatic Cancer
